Rescuing neuronal cell death by RAIDD- and PIDD- derived peptides and its implications for therapeutic intervention

Tae-Ho Jang1, In-Hye Lim2, Chang Min Kim1

  • 1School of Biotechnology and Graduate School of Biochemistry at Yeungnam University, Gyeongsan 38541, South Korea.

Scientific Reports
|August 10, 2016
PubMed

Insights

Novel peptides targeting PIDDosome formation inhibit caspase-2 activation, offering a potential therapeutic strategy against rotenone-induced neurotoxicity and neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Caspase-2 activation is implicated in oxidative-stress-induced neuronal cell death.
  • PIDDosome formation is a key pathway in caspase-2 activation.

Purpose of the Study:

  • To investigate the role of PIDDosome formation in rotenone-induced neuronal cell death.
  • To develop and evaluate novel peptides as inhibitors of PIDDosome formation and caspase-2 activation.

Main Methods:

  • Utilized rotenone to induce neurotoxicity in neuronal cells.
  • Designed and synthesized TAT-fused peptides targeting RAIDD and PIDD proteins.
  • Assessed PIDDosome formation inhibition in vitro.
  • Evaluated the effect of peptides on caspase-2-dependent apoptosis.

Main Results:

  • Rotenone-induced neuronal cell death was confirmed to be mediated by caspase-2 activation via PIDDosome formation.
  • TAT-fused peptides effectively blocked PIDDosome formation in vitro.
  • These peptides inhibited rotenone-induced apoptosis in neuronal cells.

Conclusions:

  • Targeting PIDDosome formation with peptides offers a promising approach to counteract rotenone-induced neurotoxicity.
  • The developed peptides are novel inhibitors of neuronal cell apoptosis and may serve as drug prototypes for neurodegenerative diseases.

Related Concept Videos